iSpecimen Inc. (ISPC)

Market Cap	4.13M -9.4%
Revenue (ttm)	466,302 -92.1%
Net Income	-11.42M
EPS	-21.95
Shares Out	2.52M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	40,491
Open	1.620
Previous Close	1.640
Day's Range	1.550 - 1.640
52-Week Range	1.400 - 127.200
Beta	1.63
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 14, 2026

About ISPC

iSpecimen Inc. operates marketplace that provides biospecimens to life science researchers in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It develops and operates iSpecimen Marketplace, a proprietary online marketplace platform that connects medical researchers who need access to subjects, samples, and data with hospitals, laboratories, and other organizations who have access to them. The company’s marketplace offers human biospecimens, including biofluids, such as whole blood, plasma, serum, urine, saliva, sputum, naso...

• Industry: Diagnostics & Research
• Sector: Healthcare
• IPO Date: Jun 17, 2021
• Employees: 7
• Stock Exchange: NASDAQ
• Ticker Symbol: ISPC
• Website: https://ispecimen.com

Financial Performance

In 2025, iSpecimen's revenue was $1.93 million, a decrease of -79.24% compared to the previous year's $9.29 million. Losses were -$10.49 million, -16.09% less than in 2024.

Data Sources: S&P Global Market Intelligence, CBOE, and more

Fundamental and historical data is provided by S&P Global Market Intelligence. Real-time stock price data is provided by CBOE and 15-minute delayed consolidated tape pricing data is provided by Nasdaq UTP.

Last checked:

Aug 27, 2026

Data Sources Report a data error